Quantitative assays show that plasma sEV-associated TDP-43 discriminates ALS from frontotemporal dementia and healthy controls with an area under the curve (AUC) > 0.9, and these levels correlate longitudinally with motor function decline over 12 months [89]. This evidence concerns the gene TARDBP and frontotemporal dementia.